Seeing Is Believing
VERA is currently covered by 7 analysts with an average price target of $45.19. This is a potential upside of $23.9 (112.26%) from yesterday's end of day stock price of $21.29.
Vera Therapeutics's activity chart (see below) currently has 13 price targets and 42 ratings on display. The stock rating distribution of VERA is 87.5% BUY and 12.5% HOLD.
Analysts average stock forecasts to be materialized ratio is 63.39% with an average time for these price targets to be met of 143.5 days.
Highest price target for VERA is $107, Lowest price target is $38, average price target is $63.57.
Most recent stock forecast was given by ANUPAM RAMA from JPMORGAN on 04-Mar-2025. First documented stock forecast 08-Jun-2021.
Currently out of the existing stock ratings of VERA, 28 are a BUY (87.5%), 4 are a HOLD (12.5%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$71
$48.57 (216.54%)
$75
1 months 14 days ago
(04-Mar-2025)
5/11 (45.45%)
$42.59 (149.91%)
271
Buy
$61
$38.57 (171.96%)
$64
1 months 22 days ago
(27-Feb-2025)
1/5 (20%)
$31.59 (107.41%)
163
Hold
$38
$15.57 (69.42%)
$34
5 months 10 days ago
(08-Nov-2024)
7/7 (100%)
$-10.09 (-20.98%)
189
Buy
$75
$52.57 (234.37%)
$20
5 months 21 days ago
(28-Oct-2024)
3/4 (75%)
$27.66 (58.43%)
252
Buy
$107
$84.57 (377.04%)
$107
6 months 17 days ago
(01-Oct-2024)
0/4 (0%)
$64.17 (149.82%)
What is VERA (Vera Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on VERA (Vera Therapeutics) with a proven track record?
Which analyst has the current lower performing score on VERA (Vera Therapeutics) with a proven track record?
Which analyst has the most public recommendations on VERA (Vera Therapeutics)?
Which analyst is the currently most bullish on VERA (Vera Therapeutics)?
Which analyst is the currently most reserved on VERA (Vera Therapeutics)?